Group | Girls | Boys | |||||||
---|---|---|---|---|---|---|---|---|---|
Inactive (n = 90) | Active (n = 92) | p | Inactive (n = 66) | Active (n = 39) | p | Inactive (n = 24) | Active (n = 53) | p | |
Fat % | 29.6 (5.9) | 25.7(7.0) | >0.001 | 29.2 (5.9) | 29.8 (5.4) | 0.90 | 30.7 (5.8) | 22.7 (6.5) | >0.001 |
SBP | 106 (12) | 106 (12) | 0.89 | 106 (10) | 104 (11) | 0.58 | 108 (11) | 108 (12) | 0.97 |
Baseline artery diameter (mm) | 3.1 (0.3) | 3.1 (0.5) | 0.73 | 3.0 (0.3) | 3.0 (0.4) | 0.67 | 3.2 (0.4) | 3.1 (0.5) | 0.90 |
FMD% | 9.1 (4.1) | 8.7 (4.2) | 0.45 | 9.1 (4.1) | 8.6 (3.9) | 0.65 | 9.2 (4.0) | 8.8 (4.4) | 0.44 |
VO2max | 43.70 (6.1) | 48.3 (6.9) | >0.001 | 43.1 (6.3) | 44.2 (5.7) | 0.16 | 45.56 (5.2) | 51.2 (6.2) | 0.01 |
E/A ratio | 2.2 (0.5) | 2.1 (0.4) | 0.78 | 2.2 (0.5) | 2.2 (0.4) | 0.36 | 2.1 (0.6) | 2.2 (0.4) | 0.64 |
CCVD risk | 0.36 (2.95) | −0.43 (2.90) | 0.40 | 0.09 (2.93) | 0.19 (3.12) | 0.87 | 1.22 (2.92) | −0.85 (2.70) | 0.01 |
At risk (%) | 23 | 13 | 0.35 | 18 | 18 | 0.99 | 37 | 10 | 0.03 |
OR CCVD risk | 1.9 | 1.0 | 0.13 | 1.0 | 1.0 | 0.99 | 5.1 | 1.0 | 0.02 |
MVPA (min) | 45 (10) | 83 (21) | >0.001 | 45 (10) | 77 (17) | >0.001 | 46 (9) | 88 (22) | >0.001 |
VPA (min) | 16 (6) | 33 (14) | >0.001 | 16 (6) | 30 (15) | >0.001 | 17 (5) | 36 (12) | >0.001 |
MPA/VPA ratio | 1.9 (0.7) | 1.6 (0.6) | >0.001 | 1.9 (0.7) | 1.7 (0.7) | 0.18 | 1.9 (0.6) | 1.6 (0.5) | >0.01 |
Sedentary (min) | 625 (80) | 585 (192) | 0.03 | 629 (84) | 573 (59) | >0.001 | 613(68) | 594 (248) | 0.53 |